recent publications

• academic article

  • Brener, S. J., Lincoff, A. M., Bates, E. R., Jia, G., Armstrong, P. W., Guetta, V., Hochman, J. S., Savonitto, S., Wilcox, R. G., White, H. D., Topol, E. J., Investigators, Gusto V. The relationship between baseline risk and mortality in st-elevation acute myocardial infarction treated with pharmacological reperfusion: Insights from the global utilization of strategies to open occluded arteries (gusto) v trial American Heart Journal  2005 150:89-93  DOI:10.1016/j.ahj.2005.01.030  PMID:16084153
  • Gurm, H. S., Lincoff, A. M., Lee, D., Tang, W. H. W., Jia, G., Booth, J. E., Califf, R. M., Ohman, E. M., Van de Werf, F., Armstrong, P. W., Guetta, V., Wilcox, R., et al. Outcome of acute st-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein iib/iiia inhibition - lessons from the gusto v trial Journal of the American College of Cardiology  2004 43:542-548  DOI:10.1016/j.jacc.2003.09.038  PMID:14975461
  • Lincoff, A. M., Califf, R. M., Van de Werf, F., Willerson, J. T., White, H. D., Armstrong, P. W., Guetta, V., Gibler, W. B., Hochman, J. S., Bode, C., Vahanian, A., Steg, P. G., et al. Mortality at 1 year with combination platelet glycoprotein iib/iiia inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction - gusto v randomized trial JAMA-Journal of the American Medical Association  2002 288:2130-2135  DOI:10.1001/jama.288.17.2130  PMID:12413372
  • Mukherjee, D., Gurm, H., Tang, W. H. W., Roffi, M., Wolski, K., Moliterno, D. J., Guetta, V., Ardissinio, D., Bode, C., Steg, G., Lincoff, A. M., Topol, E. J. Outcome of acute, myocardial infarction in patients with prior coronary artery bypass grafting treated with combination reduced fibrinolytic therapy and abciximab American Journal of Cardiology  2002 90:1198-1203  DOI:10.1016/s0002-9149(02)02834-5  PMID:12450598
  • Topol, E. J., Califf, R. M., Van de Werf, F., Willerson, J. T., Booth, J., White, H., Clayman, M., Deckelbaum, L., Lincoff, A. M., Ohman, E. M., Bates, E., Gibler, W. B., et al. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein iib/iiia inhibition: The gusto randomised trial Lancet  2001 357:1905-1914  PMID:11425410
  • Ellis, S. G., Guetta, V., Miller, D., Whitlow, P. L., Topol, E. J. Relation between lesion characteristics and risk with percutaneous intervention in the stent and glycoprotein iib/iiia era - an analysis of results from 10 907 lesions and proposal for new classification scheme Circulation  1999 100:1971-1976  PMID:10556223